Table 1.

Subject demographics and clinical characteristics.

Variables	Controls	Schizophrenia	P-value
Number of samples	26	24
Sex
Female	11	9	0.73b
Male	15	15
Age at deatha
(years)	62.15 ± 16.21	68.42 ± 11.03	0.12c
PMIa
(hour)	9.45 ± 11.32	16.31 ± 11.60	0.04c※
pHa	6.21 ± 0.33	6.30 ± 0.41	0.39c
CPZ-eqa	-	529.54 ± 586.72

PMI, postmortem interval; CPZeq, chlorpromazine equivalent dose.

^aData are reported as Mean ± standard deviation.

^bχ²-test.

^cStudent's t-test.

^※P < 0.05.